nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0532	0.0547	CbGbCtD
Lumiracoxib—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.05	0.0514	CbGbCtD
Lumiracoxib—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.049	0.0505	CbGbCtD
Lumiracoxib—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0461	0.0474	CbGbCtD
Lumiracoxib—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0461	0.0474	CbGbCtD
Lumiracoxib—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0452	0.0465	CbGbCtD
Lumiracoxib—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0452	0.0465	CbGbCtD
Lumiracoxib—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0442	0.0455	CbGbCtD
Lumiracoxib—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0417	0.0429	CbGbCtD
Lumiracoxib—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0415	0.0427	CbGbCtD
Lumiracoxib—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0415	0.0427	CbGbCtD
Lumiracoxib—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.039	0.0401	CbGbCtD
Lumiracoxib—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0379	0.039	CbGbCtD
Lumiracoxib—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0376	0.0387	CbGbCtD
Lumiracoxib—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0376	0.0387	CbGbCtD
Lumiracoxib—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0349	0.036	CbGbCtD
Lumiracoxib—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0343	0.0352	CbGbCtD
Lumiracoxib—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0343	0.0352	CbGbCtD
Lumiracoxib—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0328	0.0338	CbGbCtD
Lumiracoxib—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0324	0.0334	CbGbCtD
Lumiracoxib—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0316	0.0325	CbGbCtD
Lumiracoxib—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0315	0.0324	CbGbCtD
Lumiracoxib—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0285	0.0293	CbGbCtD
Lumiracoxib—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0285	0.0293	CbGbCtD
Lumiracoxib—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0273	0.0281	CbGbCtD
Lumiracoxib—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.00204	0.0731	CbGeAlD
Lumiracoxib—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00197	0.0706	CbGeAlD
Lumiracoxib—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00161	0.0577	CbGeAlD
Lumiracoxib—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00157	0.0563	CbGeAlD
Lumiracoxib—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00153	0.0548	CbGeAlD
Lumiracoxib—PTGS2—endothelium—acquired immunodeficiency syndrome	0.0015	0.0538	CbGeAlD
Lumiracoxib—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.0014	0.05	CbGeAlD
Lumiracoxib—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00134	0.0478	CbGeAlD
Lumiracoxib—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000759	0.0272	CbGeAlD
Lumiracoxib—CYP2C19—blood—acquired immunodeficiency syndrome	0.000723	0.0259	CbGeAlD
Lumiracoxib—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000672	0.024	CbGeAlD
Lumiracoxib—CYP2C19—vagina—acquired immunodeficiency syndrome	0.00067	0.024	CbGeAlD
Lumiracoxib—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000642	0.023	CbGeAlD
Lumiracoxib—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00062	0.0222	CbGeAlD
Lumiracoxib—CYP1A2—blood—acquired immunodeficiency syndrome	0.000591	0.0211	CbGeAlD
Lumiracoxib—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000589	0.0211	CbGeAlD
Lumiracoxib—CYP2C9—blood—acquired immunodeficiency syndrome	0.000561	0.0201	CbGeAlD
Lumiracoxib—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000537	0.0192	CbGeAlD
Lumiracoxib—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00052	0.0186	CbGeAlD
Lumiracoxib—CYP1A2—lung—acquired immunodeficiency syndrome	0.000518	0.0185	CbGeAlD
Lumiracoxib—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000514	0.0184	CbGeAlD
Lumiracoxib—PTGS1—blood—acquired immunodeficiency syndrome	0.000512	0.0183	CbGeAlD
Lumiracoxib—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000493	0.0176	CbGeAlD
Lumiracoxib—PTGS2—blood—acquired immunodeficiency syndrome	0.000489	0.0175	CbGeAlD
Lumiracoxib—PTGS1—vagina—acquired immunodeficiency syndrome	0.000475	0.017	CbGeAlD
Lumiracoxib—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000473	0.0169	CbGeAlD
Lumiracoxib—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000471	0.0169	CbGeAlD
Lumiracoxib—PTGS2—vagina—acquired immunodeficiency syndrome	0.000454	0.0162	CbGeAlD
Lumiracoxib—PTGS1—lung—acquired immunodeficiency syndrome	0.000449	0.0161	CbGeAlD
Lumiracoxib—PTGS2—lung—acquired immunodeficiency syndrome	0.000429	0.0153	CbGeAlD
Lumiracoxib—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000416	0.0149	CbGeAlD
Lumiracoxib—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.0004	0.0143	CbGeAlD
Lumiracoxib—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000397	0.0142	CbGeAlD
Lumiracoxib—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000382	0.0137	CbGeAlD
Lumiracoxib—PTGS1—brain—acquired immunodeficiency syndrome	0.000318	0.0114	CbGeAlD
Lumiracoxib—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000307	0.011	CbGeAlD
Lumiracoxib—PTGS2—brain—acquired immunodeficiency syndrome	0.000304	0.0109	CbGeAlD
Lumiracoxib—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000293	0.0105	CbGeAlD
